Ad is loading...
INVYX
Price
$26.04
Change
-$0.23 (-0.88%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

INVYX vs VTSNX

Header iconINVYX vs VTSNX Comparison
Open Charts INVYX vs VTSNXBanner chart's image
Pioneer International Equity Y
Price$26.04
Change-$0.23 (-0.88%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
INVYX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
INVYX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INVYX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. INVYX (735M). VTSNX pays higher dividends than INVYX: VTSNX (3.29) vs INVYX (1.29). INVYX was incepted earlier than VTSNX: INVYX (16 years) vs VTSNX (14 years). INVYX is a more actively managed with annual turnover of: 38.00 vs. VTSNX (4.00). INVYX (5000000) and VTSNX (5000000) have matching initial minimum investment requirements. INVYX annual gain was more profitable for investors over the last year : 12.48 vs. VTSNX (10.92). INVYX return over 5 years is better than : 26.94 vs. VTSNX (15.91).
INVYXVTSNXINVYX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years14 years-
Gain YTD5.7254.535126%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets735M442B0%
Annual Yield % from dividends1.293.2939%
Returns for 1 year12.4810.92114%
Returns for 3 years-3.85-5.8666%
Returns for 5 years26.9415.91169%
Returns for 10 years36.3229.81122%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals